Mentions in press and media 14
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 23, 2024 | American College of Lifestyle Medicine supports proposed law requiring protections for children from ultra-processed, sugar-sweetened foods and beverages | ACLM The medical professional society representing 11,000 health professionals nationwide calls the bill an important step in helping children and their families make healthy food choices. ST. LOUIS, April 23, 2024 /PRNewswire-PRWeb/ -- The... |
| Nov 8, 2022 | Democratic Rep. Peter Welch faces off against Republican Gerald Malloy in Vermont's US Senate election | Wilson Ring/AP Photo; Insider Redeem now Explore more race results below. Democratic Rep. Peter Welch is running against Republican Gerald Malloy to represent Vermont in the US Senate. Welch has represented Vermont's at-large congressional ... |
| Nov 12, 2021 | A Democratic congressman disclosed his wife's ExxonMobil stock sale late — days after he grilled the oil company's CEO at an oversight hearing | Democratic Rep. Peter Welch of Vermont questions ExxonMobil CEO Darren Woods during a congressional hearing on October 28, 2021. C-SPAN Welch is an outspoken environmentalist and government-reform advocate. The congressman questioned ExxonM... |
| Aug 31, 2021 | A jog down memory lane: How many times have Democrats tried and failed to win drug price negotiations? | After more than a decade of failed attempts at passing a bill to allow Medicare to negotiate drug prices, Democrats this autumn may be on the cusp of vanquishing their past. Since at least 2007, various forms of drug pricing ... |
| Jun 27, 2021 | The FDA is broken. It’s controversial approval of an ineffective new Alzheimer’s drug proves the agency puts profit over public health. | The way medicinal science is funded and rubber-stamped in this country has less to do with public health than it does with profit. Skye Gould/Insider The agency’s approval of a new Alzheimer’s drug rightly caused an uproar. But the problems... |
| Jun 27, 2021 | The FDA is broken. Its controversial approval of an ineffective new Alzheimer's drug proves the agency puts profit over public health. | The way medicinal science is funded and rubber-stamped in this country has less to do with public health than it does with profit. Skye Gould/Insider This story is available exclusively to Insider subscribers. Become an Insider and start re... |
| Jun 16, 2021 | Opinion: CMS needs to do FDA’s job and limit the use of Biogen’s pricey new Alzheimer’s drug | Now that the FDA has approved Biogen’s expensive new Alzheimer’s drug with little clinical benefit potential, but plenty of potential to speed the bankruptcy of the government’s health care program for seniors, it’ll be ... |
| Dec 20, 2020 | Save Our Stages: Stimulus Deal’s $15 Billion Grant Could Give Indie Venues ‘A Fighting Chance’ | Save Our Stages: $15 billion SPA grant included in stimulus package.Star Tribune via Getty Images |
| Jan 14, 2019 | Lawmakers want feds to look at how a Bristol-Celgene deal affects prices and competition | While investors may have cheered the recent $74 billion bid that Bristol-Myers Squibb (BMY) made for Celgene (CELG), a pair of Congressional lawmakers want federal authorities to examine the extent to which such a deal may impede competitio... |
Show more
Reviews 0
FAQ about welch.house.gov
What has the press written about welch.house.gov?
Parsers VC has collected 14 articles mentioning welch.house.gov, among them “American College of Lifestyle Medicine supports proposed law requiring protections for children from ultra-processed, sugar-sweetened foods and beverages” (Apr 23, 2024) and “Democratic Rep. Peter Welch faces off against Republican Gerald Malloy in Vermont's US Senate election” (Nov 8, 2022).
Is welch.house.gov still active?
welch.house.gov is probably closed: its latest activity on Parsers VC dates from Nov 20, 2024.